Baymatob™ awarded $1.47M

BaymatobTM has been awarded $1.47M by the NSW Medical Devices Fund to further develop OliTM.  A total of four companies received funding for the 2017 round of the Medical Devices Fund with more than $6.61M being awarded. The NSW Medical Devices Fund began in 2013 and has awarded more than $41 million across 24 different technologies.

Further information on the fund and recipients can be found here

Baymatob™ CEO , Sarah McDonald, being presented with the NSW Medical Device Fund award by the Hon. Brad Hazzard (source:  supplied  and credited to Paul Lovelace)